PROK · ProKidney Corp
United States · RS rating 10 · As of 2026-11-03
| Price | 1.07 USD |
|---|---|
| 1-day change | -4.5% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 10 / 16 / 14 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 3 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -7.1% |
| Sales growth Q/Q | +3.7% |
| Distance from 52-week high | +63.0% |
| Market cap (USD) | $603.9M |